Floatz logo

Wellbutrin

GLP - 1

Mayo ClinicPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the GLP - 1 cohort.

Asset / SponsorPhaseRating
Phentermine
Mayo Clinic
Phase 4BB
Topamax
Mayo Clinic
Phase 4BB
Tirzepatide
The University of Texas Health Science Center at San Antonio
Phase 2CCC

Same molecule, other indications

Wellbutrin is also rated in:

Smoking CessationDormant
A
Indicative ·
82 / 100
View asset →
DysthymiaDormant
BBB
Indicative ·
73 / 100
View asset →
depressive disorderDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →